Compare INO & GLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INO | GLU |
|---|---|---|
| Founded | 1979 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 119.8M |
| IPO Year | 1999 | N/A |
| Metric | INO | GLU |
|---|---|---|
| Price | $1.19 | $19.91 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.75 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 8.9K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.60% |
| EPS Growth | ★ 54.18 | N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | ★ $42,220,086.00 | N/A |
| Revenue This Year | $20,156.19 | N/A |
| Revenue Next Year | $421.95 | N/A |
| P/E Ratio | ★ N/A | $31.79 |
| Revenue Growth | ★ 19.37 | N/A |
| 52 Week Low | $1.03 | $15.52 |
| 52 Week High | $2.86 | $21.69 |
| Indicator | INO | GLU |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | 54.55 |
| Support Level | N/A | $17.78 |
| Resistance Level | $1.56 | $20.17 |
| Average True Range (ATR) | 0.09 | 0.31 |
| MACD | -0.03 | 0.11 |
| Stochastic Oscillator | 21.19 | 66.80 |
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.